Search research articles
Contact Us
Filters
Showing results (31-40 of 70) with videos related to
Page
of 7
Sort By:
Transplantation Proceedings
|
April 18, 2002
Effects of cerivastatin in dyslipemia and other cardiovascular risk factors after renal transplantation
I Garcia, P Errasti, F J Lavilla, et al.
Transplantation Proceedings
|
October 1, 1988
Experimental heart preservation for 24 hours: benefits of PGE1 in a nonpulsatile coronary perfusion solution
J Herreros, A R Abaya, L Ponz, et al.
Nephron
|
July 9, 1999
Decrease of apoptosis rate in patients with renal transplantation treated with mycophenolate mofetil
F J Pardo-Mindán, P Errasti, A Panizo, et al.
Transplantation
|
April 1, 1983
Localization of major histocompatibility complex (HLA-ABC and DR) antigens in 46 kidneys. Differences in HLA-DR staining of tubules among kidneys
S V Fuggle, P Errasti, A S Daar, et al.
Virchows Archiv : an International Journal of Pathology
|
September 19, 2000
Mast cells in chronic rejection of human renal allografts
J Pardo, L Diaz, P Errasti, et al.
Revista Espanola De Las Enfermedades Del Aparato Digestivo
|
March 15, 1974
[Hospital hepatitis. II. Prognostic possibilities of the developing sequence of enzyme activities]
M Pérez Miranda, F Borda Celaya, P Errasti Goenaga, et al.
Transplantation Proceedings
|
September 10, 2003
Treatment of hyperhomocysteinemia after renal transplantation
J Manrique, P Errasti, J Lavilla, et al.
Transplantation Proceedings
|
August 1, 1995
Adjusted survival and prognostic factors in renal transplantation
J E Robles, P Errasti, D Rosell, et al.
Transplantation Proceedings
|
August 1, 1995
Surgical complications in renal transplantation: determinant factors
J E Robles, P Errasti, J I Abad, et al.
Revista Espanola De Las Enfermedades Del Aparato Digestivo
|
March 1, 1974
[Hospital hepatitis. I. Its differential characteristics in health personnel and in patients with prolonged hemodialysis]
M Pérez Miranda, F Borda Celaya, P Errasti Goengaga, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 70) with videos related to
Sort By:
Page
of 7
Transplantation Proceedings
|
April 18, 2002
Effects of cerivastatin in dyslipemia and other cardiovascular risk factors after renal transplantation
I Garcia, P Errasti, F J Lavilla, et al.
Transplantation Proceedings
|
October 1, 1988
Experimental heart preservation for 24 hours: benefits of PGE1 in a nonpulsatile coronary perfusion solution
J Herreros, A R Abaya, L Ponz, et al.
Nephron
|
July 9, 1999
Decrease of apoptosis rate in patients with renal transplantation treated with mycophenolate mofetil
F J Pardo-Mindán, P Errasti, A Panizo, et al.
Transplantation
|
April 1, 1983
Localization of major histocompatibility complex (HLA-ABC and DR) antigens in 46 kidneys. Differences in HLA-DR staining of tubules among kidneys
S V Fuggle, P Errasti, A S Daar, et al.
Virchows Archiv : an International Journal of Pathology
|
September 19, 2000
Mast cells in chronic rejection of human renal allografts
J Pardo, L Diaz, P Errasti, et al.
Revista Espanola De Las Enfermedades Del Aparato Digestivo
|
March 15, 1974
[Hospital hepatitis. II. Prognostic possibilities of the developing sequence of enzyme activities]
M Pérez Miranda, F Borda Celaya, P Errasti Goenaga, et al.
Transplantation Proceedings
|
September 10, 2003
Treatment of hyperhomocysteinemia after renal transplantation
J Manrique, P Errasti, J Lavilla, et al.
Transplantation Proceedings
|
August 1, 1995
Adjusted survival and prognostic factors in renal transplantation
J E Robles, P Errasti, D Rosell, et al.
Transplantation Proceedings
|
August 1, 1995
Surgical complications in renal transplantation: determinant factors
J E Robles, P Errasti, J I Abad, et al.
Revista Espanola De Las Enfermedades Del Aparato Digestivo
|
March 1, 1974
[Hospital hepatitis. I. Its differential characteristics in health personnel and in patients with prolonged hemodialysis]
M Pérez Miranda, F Borda Celaya, P Errasti Goengaga, et al.
Page
of 7